Consumer and multidisciplinary clinician experiences after implementation of the Drug Burden Index intervention bundle to facilitate deprescribing in older inpatients: A mixed method study
Journal of Evaluation in Clinical Practice · 2025
DOI: 10.1111/jep.14220 ↗Kurz gefasst
Mixed-Methods-Studie in der Zeitschrift Journal of Evaluation in Clinical Practice, 2025. Verfasst von Nashwa Masnoon und 7 weiteren Autor:innen. Beteiligte Einrichtung: Kolling Institute, Faculty of Medicine and Health, The University of Sydney and Northern Sydney Local Health District, Sydney, New South Wales, Austr…. Hauptthemen laut MEDLINE: Deprescriptions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Health and Medical Research Council Targeted Research on Frailty in Hospital Care, Rothwell Fellowship in Geriatric Pharmacotherapy, Penney Ageing Research Trust Fund, Royal North Shore Hospital.
Abstract (Originalsprache)
Rationale
The Drug Burden Index (DBI) measures exposure to anticholinergic and sedative drugs, which are associated with harm in older adults. To facilitate deprescribing in older Australian inpatients, we piloted an intervention bundle integrating the DBI in Electronic Medical Records, clinician deprescribing guides, consumer information leaflets and a stewardship pharmacist.
Objectives
To understand (i) hospital clinician experiences of using the bundle and (ii) consumer (patient and carer) and General Practitioner (GP) experiences of in‐hospital deprescribing, following bundle implementation.
Methods
Hospital clinicians from target services (General and Geriatric Medicine) at an Australian metropolitan tertiary‐referral hospital, were invited to complete surveys, including the System Usability Scale (SUS), and interviews. Patients aged ≥75 years with high DBI (DBI ≥1) were admitted to target services, and their carers, received interview invitations. Consenting patients’ GPs received surveys. Qualitative data was thematically analysed. Hospital clinician interviews were mapped to the Human Organisation Technology‐fit Framework. Patient interviews were mapped to an adaptation of the National Health Service Patient Experience Framework.
Results
Seventeen hospital clinicians ( n = 15 medical, n = 2 pharmacists) and four GPs completed surveys. Eight hospital clinicians ( n = 7 medical, n = 1 pharmacist), seven patients and two carers completed interviews. Hospital clinicians reported good usability (SUS score 71.5 ± 12.5). Most themes were around system use and user satisfaction. They reported the intervention was useful for medication review, identified challenges from pre‐existing heavy workload and suggested further integration into workflows. Patients and carers reported themes around information, communication and education. Patients reported feeling better or no different post‐deprescribing. Patients, carers and GPs described poor communication regarding in‐hospital medication changes and their rationale.
Conclusions
The intervention was well accepted by hospital clinicians. The bundle requires further integration into workflows for sustainability and assessment of generalisability in other health services. Given patients, carers and GPs reported poor medication‐related communication, future interventions may target this.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Kolling Institute, Faculty of Medicine and Health, The University of Sydney and Northern Sydney Local Health District, Sydney, New South Wales, Australia.
- Biomedical Informatics and Digital Health, School of Medical Sciences, Faculty of Medicine and Health, Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
- New South Wales Therapeutic Advisory Group, Sydney, New South Wales, Australia.
- Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
- School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
- Departments of Clinical Pharmacology and Aged Care, Royal North Shore Hospital, Sydney, NSW, Australia.
ORCID-Profile: Nashwa Masnoon
Förderung
- National Health and Medical Research Council Targeted Research on Frailty in Hospital Care
- Rothwell Fellowship in Geriatric Pharmacotherapy
- Penney Ageing Research Trust Fund, Royal North Shore Hospital
- New South Wales Health Translational Research Grant Scheme 274, Reducing Inappropriate Polypharmacy in Older Inpatients
Zitieren
APA
Masnoon, N., Lo, S., Baysari, M., Bennett, A., McLachlan, A. J., Blyth, F., Duong, M., & Hilmer, S. N. (2025). Consumer and multidisciplinary clinician experiences after implementation of the Drug Burden Index intervention bundle to facilitate deprescribing in older inpatients: A mixed method study. Journal of Evaluation in Clinical Practice. https://doi.org/10.1111/jep.14220
Vancouver
Masnoon N, Lo S, Baysari M, Bennett A, McLachlan AJ, Blyth F, et al. Consumer and multidisciplinary clinician experiences after implementation of the Drug Burden Index intervention bundle to facilitate deprescribing in older inpatients: A mixed method study. Journal of Evaluation in Clinical Practice. 2025. doi:10.1111/jep.14220
BibTeX
@article{Masnoon2025,
author = {Masnoon, Nashwa and Lo, Sarita and Baysari, Melissa and Bennett, Alexandra and McLachlan, Andrew J and Blyth, Fiona and Duong, Mai and Hilmer, Sarah N},
title = {Consumer and multidisciplinary clinician experiences after implementation of the Drug Burden Index intervention bundle to facilitate deprescribing in older inpatients: A mixed method study},
journal = {Journal of Evaluation in Clinical Practice},
year = {2025},
doi = {10.1111/jep.14220}
}
EUVIMED